Joel Greenblatt's IMVT Position Overview
Joel Greenblatt (via Gotham Asset Management, LLC) currently holds 30,100 shares of Immunovant, Inc. (IMVT) worth $1.16 M, representing 0.00% of the portfolio. First purchased in 2023-Q3, this short-term holding has been held for 3 quarters.
Based on 13F filings, Joel Greenblatt has maintained this position in IMVT for several quarters, showing initial confidence in the investment. Largest addition occurred in Q2 2026, adding 30,100 shares. Largest reduction occurred in Q4 2023, reducing 5,527 shares.
Analysis based on 13F filings available since 2013 Q2
Joel Greenblatt's Immunovant (IMVT) Holding Value Over Time
Track share changes against reported price movement
Quarterly Immunovant (IMVT) Trades by Joel Greenblatt
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +30,100 | New Buy | 30,100 | $38.53 |
| Q4 2023 | -5,527 | Sold Out | 0 | $0.00 |
| Q3 2023 | +5,527 | New Buy | 5,527 | $38.39 |
Joel Greenblatt's Immunovant Investment FAQs
Joel Greenblatt first purchased Immunovant, Inc. (IMVT) in Q3 2023, acquiring 5,527 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt has held Immunovant, Inc. (IMVT) for 3 quarters since Q3 2023.
Joel Greenblatt's largest addition to Immunovant, Inc. (IMVT) was in Q2 2026, adding 30,100 shares worth $1.16 M.
According to the latest 13F filing for Q2 2026, Joel Greenblatt's firm, Gotham Asset Management, LLC, owns 30,100 shares of Immunovant, Inc. (IMVT), valued at approximately $1.16 M.
As of the Q2 2026 filing, Immunovant, Inc. (IMVT) represents approximately 0.00% of Joel Greenblatt's publicly disclosed stock portfolio, making it one of their key holdings.
Joel Greenblatt's peak holding in Immunovant, Inc. (IMVT) was 30,100 shares, as reported at the end of Q2 2026.